CTNS and lysosomal storage disease: We studied the potential of CTNS mRNA therapy to ameliorate cystinosis, a monogenic lysosomal storage disorder having a well-defined phenotype, presenting with cystine accumulation and both podocyte and proximal tubular dysfunction in the kidney.